PNPLA3 and metabolic dysfunction-associated steatotic liver disease: It is worth noting that the link between PNPLA3 I148M variant and NAFLD is independent of metabolic syndrome (MS) and its features; that is, most of patients carrying this variant are not associated with obesity, diabetes, and atherogenic dyslipidemia, as demonstrated in the recent meta-analysis [129].